Succinylcholine Chloride Injection, Solution
Product Images NDC 70069-783

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 70069-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (5c6877a5 1296 4619 9a7c 01dae4ddf5ac 01)

Chemical structure of Succinylcholine Chloride showing the molecular arrangement including ester groups, quaternary ammonium groups, and chloride ions. The structure illustrates the positions of carbon, nitrogen, oxygen atoms, and the positive charges on nitrogens balanced by two chloride anions.*

FDA Label Image

Image (5c6877a5 1296 4619 9a7c 01dae4ddf5ac 02)

Label for Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL) multiple dose vial for intravenous or intramuscular use. The label highlights a warning for paralyzing agent effect and storage instructions to refrigerate at 2° to 8°C. Manufactured for Somerset Therapeutics, LLC, with product barcode and manufacturing information visible.*

FDA Label Image

Image (5c6877a5 1296 4619 9a7c 01dae4ddf5ac 03)

The packaging label for Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL) multiple dose vials. The label indicates intravenous or intramuscular use, includes storage instructions (refrigerate 2°-8°C), and a warning in red about its paralyzing effect and respiratory arrest risk. Manufactured for Somerset Therapeutics, LLC, Hollywood, FL, with a barcode and NDC 70069-783-10.*

FDA Label Image

Image (5c6877a5 1296 4619 9a7c 01dae4ddf5ac 04)

Label for Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) by Somerset Therapeutics LLC. The product is a solution for injection, indicated for intravenous or intramuscular use. The label includes warnings about its paralytic effects and storage instructions to keep refrigerated at 2° to 8°C (36° to 46°F). The packaging shows multiple dose vials with barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.